Alimera Sciences | ALIM - Operating Profit

Alimera Sciences reported $-3411000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Operating Profit Change
Abbvie ABBV:US USD 5.5B 899M
Alimera Sciences ALIM:US USD -3411000 1.44M
Bayer BAYN:GR EUR 1.43B 233M
Insmed INSM:US USD -151475000 23.78M
Novartis NOVN:VX USD 1.95B 219M
Regeneron Pharmaceuticals REGN:US USD 1.15B 76.9M
Roche Holding ROG:VX 5.93B 5.62B